Dry eye arises when the tear film is unstable, either because the eyes produce insufficient tears or because the oily layer that slows evaporation is inadequate. Age-related changes, hormonal shifts, chronic eyelid inflammation and meibomian gland dysfunction are common internal contributors. Environmental and lifestyle factors such as low humidity, prolonged screen time, wind or smoke exposure and extended contact lens wear also accelerate tear evaporation.

Systemic health issues and certain medications can further reduce tear production or alter tear quality. Autoimmune conditions, thyroid disease and some antidepressants or antihistamines are known contributors. Identifying the combination of factors affecting a particular patient is essential to creating an effective treatment plan.

Risk increases with age, and women are often more susceptible because of hormonal influences, particularly during menopause. People who spend long hours on digital devices, work in dry indoor environments, or are frequent contact lens wearers face elevated risk due to reduced blink rate and increased tear evaporation. Occupational exposures such as wind, dust or air conditioning can also make symptoms more likely.

Medical history plays a significant role: patients with autoimmune disease, thyroid disorders, or a history of ocular surface inflammation commonly experience chronic dry eye. Certain medications that affect tear production contribute to the problem, so a thorough medication review is part of any risk assessment. Early recognition of risk factors supports targeted prevention and management.

Common symptoms include burning, stinging or a gritty sensation as if something is in the eye, which may be intermittent or persistent. Patients frequently report fluctuating or blurred vision, light sensitivity, eye fatigue and difficulty wearing contact lenses comfortably. Paradoxical tearing can occur when reflex tearing responds to an unstable tear film, which can confuse people about the underlying dryness.

Symptoms that worsen with reading, computer use, or in dry or windy environments are especially suggestive of dry eye disease. If symptoms interfere with daily activities, work or sleep, an evaluation is warranted to determine the subtype and appropriate treatment. Timely assessment helps prevent surface damage and preserve visual quality.

A comprehensive evaluation includes a medical history, medication review and inspection of the eyelids, lashes and ocular surface to look for inflammation, blockage or gland dropout. Clinicians observe blink patterns and may perform vital dye staining to highlight surface damage and measure tear breakup time to assess tear film stability. Tear osmolarity testing can quantify tear concentration, and meibography images the meibomian glands to detect structural changes that impair oil production.

These noninvasive tests are combined to determine whether the condition is primarily evaporative or related to reduced tear production, which guides therapy. Additional measures such as tear volume testing or surface imaging may be used for complex cases. The diagnostic process creates an objective baseline to monitor response to treatment over time.

Several practical steps often reduce symptoms and support gland function, including consistent eyelid hygiene, warm compresses and gentle lid massage to encourage meibomian oil flow. Increasing indoor humidity, positioning fans away from the face and taking regular screen breaks with deliberate blinking help reduce evaporative loss. Over-the-counter lubricating drops and nighttime ointments provide symptomatic relief and protect the ocular surface during sleep.

Maintaining hydration, reviewing systemic medications with your primary care provider, and protecting the eyes from wind or smoke are additional lifestyle measures that contribute to control. For many patients these conservative strategies form the foundation of care and may be sufficient when combined with periodic monitoring. If symptoms persist, a clinician can recommend escalation to prescription or in-office therapies.

Prescription therapies are considered when conservative measures do not adequately control symptoms or when objective testing shows inflammation or reduced tear production. Topical anti-inflammatory medications and immunomodulators can decrease ocular surface inflammation and support healthier tear film function over time. Secretagogues or other agents that promote tear production may be appropriate in aqueous-deficient cases, depending on the underlying cause.

Treatment selection is individualized based on exam findings, test results and patient goals, and clinicians monitor for effectiveness and side effects. In some situations a short course of prescription therapy is followed by maintenance with lubricants and lifestyle changes. Regular follow-up ensures therapy is adjusted if the condition evolves.

Several office-based treatments target blocked or dysfunctional meibomian glands, restoring oil flow and improving tear stability. Thermal pulsation and mechanical expression apply controlled heat and pressure to clear gland obstructions, which can significantly reduce evaporative dry eye in appropriate candidates. Intense pulsed light (IPL) therapy is another option that can reduce lid inflammation and improve gland performance for selected patients.

Punctal occlusion, either temporary or permanent, conserves tears on the ocular surface by reducing drainage and may be used alongside other treatments. A clinician will recommend procedures based on gland imaging, symptom severity and response to conservative care. Combining in-office therapies with ongoing home maintenance often produces the best long-term outcomes.

Contact lenses can exacerbate dry eye symptoms by disrupting the tear film and increasing friction between the lens and the ocular surface. Many patients benefit from switching to contact lens designs with higher moisture retention, daily disposables, or specialty lenses such as scleral lenses that provide a fluid reservoir to protect the cornea. Lens material, fit and wearing schedule should be reviewed when dryness becomes a problem.

Adjunctive strategies like tailored lubricating drops compatible with contact lenses, limiting extended wear and optimizing blink habits help many wearers continue using contacts comfortably. If contact lens intolerance persists despite these measures, alternative vision correction or specialty lenses may be explored. A contact lens fitting that considers dry eye causes and tear quality is essential for successful long-term wear.

Small but consistent changes to your environment and routines can meaningfully reduce tear evaporation and ocular surface stress. Increase indoor humidity, position screens slightly lower to encourage full blinking, take frequent breaks during visual tasks and avoid direct airflow from vents or fans. Wearing wraparound eyewear outdoors and protecting your eyes from smoke or wind also minimizes exposure that accelerates tear loss.

Good eyelid hygiene and periodic warm compresses maintain meibomian gland function and should be incorporated when early symptoms appear. Staying well hydrated and discussing systemic medications with your healthcare providers can address modifiable contributors. Preventive attention slows progression and reduces the need for more intensive interventions.

You should seek an evaluation if you experience persistent burning, gritty sensations, recurrent blurry vision, or contact lens discomfort that interferes with daily activities. Symptoms that worsen with reading, computer work or in dry environments warrant a clinical assessment to determine the underlying cause and start appropriate treatment before surface damage occurs. Sudden onset of severe pain, vision loss or acute redness requires prompt attention to rule out other ocular emergencies.

For chronic or recurrent symptoms, schedule a comprehensive dry eye assessment so objective testing can guide a targeted care plan. Early diagnosis often leads to better outcomes and less need for invasive therapies. Regular follow-up allows your provider to monitor response and adapt the strategy as needed.

An evaluation typically begins with a discussion of your symptoms, medical history and current medications, followed by an external eyelid and ocular surface exam to look for inflammation or gland dysfunction. The clinician may perform noninvasive tests such as tear breakup time, vital dye staining and osmolarity measurement, and may use meibography to image the meibomian glands when indicated. These assessments clarify whether the problem is evaporative, aqueous-deficient or mixed and establish a baseline for treatment.

Based on the findings you will receive a personalized plan that starts with conservative strategies and escalates to prescription or in-office therapies as needed, with follow-up to monitor progress. Education about daily habits, eyelid care and environmental adjustments is emphasized to support long-term control. If you have specific concerns about symptoms or contact lens wear, mention them during your visit so the exam can be tailored to your needs.